Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$0.94
-4.51%
Mkt Cap $245.64M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
+6.9%
Consensus $1.00 vs current $0.94
NASDAQ·Healthcare·Biotechnology
$0.94
-4.51%
Mkt Cap $245.64M
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$1.00
Range $1.00 – $1.00
+6.9%
Consensus $1.00 vs current $0.94